Home Tags JPM19

Tag: JPM19

Women are underrepresented as executives at healthcare companies.

Dismal statistics show there are fewer female CEOs in healthcare, even though most workers are women

Only 33% of senior leaders at healthcare companies are women, including just 13% of CEOs.

The CEO of a startup aimed at harnessing the benefits of young blood shares his real plan to beat aging

A startup called Alkahest is studying the anti-aging effects of young blood to design drugs that could fight age-related diseases like Alzheimer's and Parkinson's.
Pfizer has a new strategy for neuroscience research.

Drug giant Pfizer isn’t ready to abandon neuroscience — here’s its $150-million ‘star cluster’ strategy for betting on p...

Execs from pharma giant Pfizer shared their strategy for keeping an eye on neuroscience — if not from the front row, then at least from the sidelines.

A genetic testing company you’ve never heard of could become a household name as it takes on 23andMe

Genetics company Invitae will soon let you order personal genetic tests. But unlike its biggest rival, a clinician will still have to be involved.

We’ll get you caught up on all the news you missed at the year’s biggest healthcare investor conference

Among the highlights: an $8 billion deal (and more to come?), a promising depression drug, and a strategy deep dive from a healthcare giant.

A revolutionary drug that could treat a rare and devastating disease is prohibitively expensive. But one state has a plan to pay for its potential $5 ...

A one-time treatment for a devastating rare disease could be paid for with an installment plan in Massachusetts. That could set a roadmap for the US.

250 more hospitals just joined in on a plan to make their own drugs and the effort could upend the generic pharma business

Another 12 health systems joined an organization aiming to lower the price of prescription drugs. The hope is to make generic drugs that are in shortage or have high prices.

A drug that works differently from all existing depression drugs just got a big boost

Sage's new antidepressant may be called a "blockbuster" for good reason: it appears to be the first to differ significantly from 35 years worth of treatments.

A Silicon Valley startup that pioneered a new way to fight diabetes is tackling depression after its CEO noticed a disturbing trend

Omada Health told Business Insider it's expanding beyond treating diseases like diabetes and high cholesterol, and is now tackling depression and anxiety.

Dispensed: What we saw at JPMorgan’s big healthcare investor conference

Welcome to Dispensed: A weekly dose of pharma, biotech, and healthcare news.